Rituximab: a novel treatment for refractory Riedel’s thyroiditis

  • Hunt L
  • Harrison B
  • Bull M
  • et al.
N/ACitations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

This case report reviews the rare condition of Riedel’s thyroiditis via a patient case. The report highlights the difficulties that one may encounter when managing such a case in regards to patient symptoms, side effects of medications and the relapsing nature of the condition. The case report also highlights novel treatment in the treatment of Riedel’s thyroiditis, rituximab, how this works and the resolution of symptoms that we have achieved with our patient on this treatment.

Cite

CITATION STYLE

APA

Hunt, L., Harrison, B., Bull, M., Stephenson, T., & Allahabadia, A. (2018). Rituximab: a novel treatment for refractory Riedel’s thyroiditis. Endocrinology, Diabetes & Metabolism Case Reports, 2018. https://doi.org/10.1530/edm-17-0132

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free